1. Fenugreek (Trigonella Foenum-Graecum) Seed Flour and Diosgenin Preserve Endothelium-Dependent Arterial Relaxation in a Rat Model of Early-Stage Metabolic Syndrome
   Katalin Szabó et al, 2018, IJMS CrossRef
2. Protective Effect of a Mixture of Astragalus membranaceus and Lithospermum erythrorhizon Extract against Hepatic Steatosis in High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Mice
   Doo Jin Choi et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
3. Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
   Jianglian She et al, 2022, Front. Pharmacol. CrossRef
4. Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid/Amino Acid Metabolism in High Fat Diet-Fed Rats
   Yuan Zhou et al, 2022, Front. Pharmacol. CrossRef
5. Diosgenin and Its Analogs: Potential Protective Agents Against Atherosclerosis
   Dan Wang et al, 2022, DDDT CrossRef
6. Diosgenin: An ingress towards solving puzzle for diabetes treatment
   Prajya Arya et al, 2022, Journal of Food Biochemistry CrossRef
7. Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
   Songling Jiang et al, 2022, Diabetes Metab J CrossRef
8. Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications
   Lvzhuo Zhang et al, 2024, Phytotherapy Research CrossRef
9. Liraglutide mitigates dexamethasone-induced fatty acid synthase (FASN) and the cluster of differentiation36 (CD36) expression: a potential treatment for glucocorticoid-induced non-alcoholic fatty liver disease (NAFLD)
   Dahshan Hassan Selim et al, 2025, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef